Delivery Order SPE2DB24D2003-SPE2DB25FXMU6
- Not listed
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on August 28, 2025, for the supply of Advair HFA 230/21 microgram inhalers in 12-gram units, with a contract ceiling value of $1,608.05. This firm fixed-price delivery order, which is due for completion by August 29, 2025, represents a non-competitive procurement under AmerisourceBergen's existing Indefinite Delivery Contract with DLA Troop Support Medical (designated SPE2DX). The pharmaceutical product will...
- The Defense Logistics Agency awarded a $5,298.87 firm fixed-price delivery order to AmerisourceBergen Drug Corp for Advair HFA 115-21 microgram inhalers (12 gram units) on July 22, 2025, with completion expected by July 23, 2025. This non-set-aside contract represents a child delivery order under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, designated SPE2DX, which is valued at $999,999,999 and extends through December 2026. The IDC serves as a...
- The Defense Logistics Agency awarded a delivery order valued at $2,335.16 to AmerisourceBergen Drug Corp for Advair HFA 115-21 microgram inhalers (12 grams) on August 28, 2025, with an ultimate completion date of August 29, 2025. This is a firm fixed price, non-set-aside contract with performance at the vendor's Conshohocken, Pennsylvania location. The delivery order represents a small-value transaction under AmerisourceBergen's existing indefinite delivery contract with DLA Troop Support...
- The Defense Logistics Agency awarded a delivery order valued at $13,669.86 to AmerisourceBergen Drug Corp for Advair HFA 230-21 mcg inhaler 12gm on August 5, 2025, with an ultimate completion date of August 6, 2025. This non-set-aside, competitively awarded contract utilizes firm fixed price pricing and represents a child order under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, designated SPE2DX, which is valued at $999,999,999.00 and extends...
- AmerisourceBergen Drug Corp was awarded a delivery order contract valued at $7,838.23 by the Defense Logistics Agency (DLA) on September 4, 2025, for the supply of Advair HFA 115-21 mcg inhaler in 12-gram units. This is a firm fixed-price, non-set-aside delivery order with an ultimate completion date of September 5, 2025, with performance to be executed at the contractor's facility in Conshohocken, Pennsylvania. The delivery order is executed under AmerisourceBergen's larger Indefinite...
- The Defense Logistics Agency awarded a delivery order valued at $1,745.46 to AmerisourceBergen Drug Corp for the supply of Advair HFA 230-21 mcg inhalers (12 gm) on April 21, 2025, with completion expected by April 22, 2025. This non-competitive, firm fixed-price delivery order was issued under AmerisourceBergen's existing Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, designated SPE2DX, which carries a potential value of $999,999,999.00 through December 2026. The product...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on July 25, 2025, for the supply of Advair HFA 230-21 mcg inhalers (12 gm) valued at $2,091.24. This is a firm fixed-price delivery order with an ultimate completion date of July 28, 2025, and represents a non-competitive set-aside award. The contract will be performed at AmerisourceBergen's corporate headquarters in Conshohocken, Pennsylvania. This delivery order is issued under AmerisourceBergen's larger...
- The Defense Logistics Agency (DLA) awarded a delivery order to AmerisourceBergen Drug Corp on August 19, 2025, for the supply of Advair HFA 230-21 mcg inhalers (12 gm) valued at $4,403.25. This is a firm fixed-price delivery order with no set-aside designation, indicating the award was made through open competition. The contract is set to conclude by August 20, 2025, and will be performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. This delivery order falls...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on August 5, 2025, for the supply of Advair HFA 115-21 micrograms inhaler in 12-gram units, valued at $9,119.12. The award is a firm fixed price delivery order with an ultimate completion date of August 6, 2025, and carries no set-aside designation, indicating it was awarded through open competition. AmerisourceBergen Drug Corp, headquartered in Conshohocken, Pennsylvania, will fulfill this order from its...
- The Defense Logistics Agency awarded a delivery order valued at $2,210.11 to AmerisourceBergen Drug Corp for Advair HFA 230-21 microgram inhalers (12-gram units) on August 4, 2025, with completion scheduled for August 5, 2025. This non-set-aside contract utilized firm fixed pricing and was performed at the vendor's Corporate Office location in Conshohocken, Pennsylvania. The delivery order represents a child contract under AmerisourceBergen Drug Corp's larger Indefinite Delivery Contract (IDC)...
- SPE2DB24D2003Indefinite Delivery Contract
- SPE2DB24D2003-SPE2DB25FXMU6Delivery Order
The Defense Logistics Agency awarded a $1,879.53 firm fixed-price delivery order to AmerisourceBergen Drug Corp on September 16, 2025, for the supply of Advair HFA 115-21 mcg inhaler in 12-gram units. This non-set-aside contract represents a child order under AmerisourceBergen's larger Indefinite Delivery Contract with DLA Troop Support Medical (SPE2DX), valued at $999,999,999.00 and extending through December 2026. The ultimate completion date for this delivery order is set for September 17, 2025, with performance occurring at the contractor's Conshohocken, Pennsylvania facility. AmerisourceBergen Drug Corp, a major pharmaceutical distributor headquartered in Pennsylvania, maintains a significant role in the federal medical supply chain, particularly supporting military and veteran healthcare systems. The company's primary IDC vehicle enables comprehensive pharmaceutical support globally, encompassing specialty medications, brand-name and generic drugs, vaccines, and related medical supplies across multiple therapeutic domains. This delivery order for Advair HFA—a corticosteroid/long-acting beta-agonist inhaler used for asthma and chronic obstructive pulmonary disease management—exemplifies the contractor's ongoing role in fulfilling critical pharmaceutical needs for the Defense Health Agency and other federal healthcare systems.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $1.9k | 9/16/25 |